Helping you stay current in drug monitoring

 

Prescribing During the Pandemic

The COVID-19 pandemic has disrupted the delivery of care across the country, including for patients receiving chronic pain medications and medication-assisted treatment (MAT) for substance use disorder. To minimize these disruptions, federal agencies have made important exceptions to standard prescribing regulations, as outlined in a previous blog.

Oct 21 2020
 
 

Impact of COVID-19 on Drug-Related Deaths

The COVID-19 pandemic has likely contributed to an increase in opioid-related deaths in the United States, according to Nora Volkow, Director of the National Institute on Drug Abuse, part of the National Institutes of Health. She spoke with NIH Director Francis Collins in a recent web conversation.

Oct 07 2020